D. Western Therapeutics Institute, Inc. (TYO:4576)
Japan · Delayed Price · Currency is JPY 88.00
0.00 (0.00%)
Aug 27, 2026, 3:30 PM JST
TYO:4576 Cash Flow Statement
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -636 | -630 | -1,288 | -826 | -440 | -159 |
Depreciation & Amortization | 26 | 47 | 49 | 48 | 46 | 45 |
Loss (Gain) From Sale of Assets | - | - | - | 6 | - | - |
Loss (Gain) From Sale of Investments | - | - | - | 12 | 100 | - |
Other Operating Activities | -1 | -1 | -3 | 2 | 1 | -3 |
Change in Accounts Receivable | -15 | 30 | -7 | 53 | -113 | -9 |
Change in Inventory | -28 | 15 | -14 | 22 | 9 | -30 |
Change in Accounts Payable | -55 | -19 | -74 | 95 | 22 | 4 |
Change in Other Net Operating Assets | 84 | 65 | 38 | 2 | 21 | -24 |
Operating Cash Flow | -625 | -493 | -1,299 | -586 | -354 | -176 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -6 | -2 | -9 | -12 | -9 | -2 |
Sale (Purchase) of Intangibles | - | - | -1 | -2 | - | - |
Investment in Securities | - | - | - | - | -130 | -109 |
Other Investing Activities | -595 | - | - | -1 | - | - |
Investing Cash Flow | -601 | -2 | -10 | -15 | -139 | -111 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 135 | 886 | 166 | 913 | - |
Long-Term Debt Repaid | - | -328 | -1,034 | -120 | -120 | -120 |
Net Debt Issued (Repaid) | 65 | -193 | -148 | 46 | 793 | -120 |
Issuance of Common Stock | 1,101 | 1,272 | 715 | 88 | 87 | 15 |
Other Financing Activities | 1 | 1 | - | - | -13 | 1 |
Financing Cash Flow | 1,167 | 1,080 | 567 | 134 | 867 | -104 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | - | - | - | - | 28 | 17 |
Miscellaneous Cash Flow Adjustments | -3 | -2 | 1 | - | -2 | - |
Net Cash Flow | -62 | 583 | -741 | -467 | 400 | -374 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -631 | -495 | -1,308 | -598 | -363 | -178 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -255.47% | -127.91% | -277.71% | -139.72% | -81.03% | -42.99% |
Free Cash Flow Per Share | -11.81 | -10.33 | -37.24 | -18.82 | -12.25 | -6.07 |
Levered Free Cash Flow | -453.5 | -318.5 | -871.38 | -317 | -225.13 | -126 |
Unlevered Free Cash Flow | -446.63 | -313.5 | -868.25 | -315.75 | -223.25 | -123.5 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 11 | 9 | 5 | 2 | 2 | 4 |
Cash Income Tax Paid | - | 1 | 1 | 1 | 1 | 1 |
Change in Working Capital | -14 | 91 | -57 | 172 | -61 | -59 |